These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37481147)

  • 1. Investigation of the color discrimination ability using the Farnsworth-Munsell 100-hue test and structural changes by SS-OCT in patients with transfusion-dependent beta-thalassemia.
    Koctekin B; Dogan B; Erdem R; Buber H; Kurtoglu E; Karakus V
    Photodiagnosis Photodyn Ther; 2023 Sep; 43():103716. PubMed ID: 37481147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of relationship between colour discrimination ability and stereoscopic acuity using Farnsworth Munsell 100 hue test and stereo tests.
    Koctekin B; Coban DT; Ozen M; Tekindal MA; Unal AC; Altintas AGK; Gundogan NU
    Can J Ophthalmol; 2020 Apr; 55(2):131-136. PubMed ID: 31712007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of age-related cataracts on colour perception, postoperative recovery and related spectra derived from test of hue perception.
    Ao M; Li X; Qiu W; Hou Z; Su J; Wang W
    BMC Ophthalmol; 2019 Feb; 19(1):56. PubMed ID: 30786855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color discrimination assessment in patients with hypothyroidism using the Farnsworth-Munsell 100 hue test.
    Racheva K; Totev T; Natchev E; Bocheva N; Beirne R; Zlatkova M
    J Opt Soc Am A Opt Image Sci Vis; 2020 Apr; 37(4):A18-A25. PubMed ID: 32400512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of eye dominancy with color vision discrimination performance ability in normal subjects.
    Koçtekin B; Gündoğan NÜ; Altıntaş AG; Yazıcı AC
    Int J Ophthalmol; 2013; 6(5):733-8. PubMed ID: 24195058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of color perception in individuals addicted to narcotic substances in the Farnsworth-Munsell 100-Hue test].
    Nadolska K; Goś R
    Med Pr; 2016 Dec; 67(6):777-785. PubMed ID: 28005086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Computer-Based Farnsworth-Munsell 100-Hue (CFM-100) Test in Pilots' Medical Assessments.
    Zhang Y; Ma J; Cheng S; Hu W
    Aerosp Med Hum Perform; 2022 Apr; 93(4):362-367. PubMed ID: 35354515
    [No Abstract]   [Full Text] [Related]  

  • 8. Optical coherence tomography angiography findings in transfusion-dependent beta-thalassemia patients with and without splenectomy.
    Koctekin B; Karakus V; Dogan B; Erdem R; Dogan U; Buber H; Kurtoglu E
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103282. PubMed ID: 36639006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis.
    Yuksel B; Dogan B; Koctekin B; Atis N; Erdal A; Kurtulus F; Erol MK; Gomceli YB
    J Clin Neurosci; 2019 Mar; 61():48-53. PubMed ID: 30455132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing a new computer-based test for the clinical evaluation of color discrimination.
    Melamud A; Simpson E; Traboulsi EI
    Am J Ophthalmol; 2006 Dec; 142(6):953-60. PubMed ID: 17157581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
    Nousiainen I; Kälviäinen R; Mäntyjärvi M
    Ophthalmology; 2000 May; 107(5):884-8. PubMed ID: 10811079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoring the Farnsworth-Munsell 100-hue for vocational guidance.
    Mahon LE; Vingrys AJ
    Optom Vis Sci; 1995 Aug; 72(8):547-51. PubMed ID: 8539021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new computer-based Farnsworth Munsell 100-hue test for evaluation of color vision.
    Ghose S; Parmar T; Dada T; Vanathi M; Sharma S
    Int Ophthalmol; 2014 Aug; 34(4):747-51. PubMed ID: 24097078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
    Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
    Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatic visual evoked potentials in young patients with demyelinating disease.
    Pompe MT; Brecelj J; Kranjc BS
    J Opt Soc Am A Opt Image Sci Vis; 2014 Apr; 31(4):A82-6. PubMed ID: 24695207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dental Shade Matching and Value Discernment Abilities of First-Year Dental Students.
    Imbery TA; Tran D; Baechle MA; Hankle JL; Janus C
    J Prosthodont; 2018 Dec; 27(9):821-827. PubMed ID: 29533495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of the color discrimination impairment along the blue-yellow axis in patients with hypothyroidism after treatment with levothyroxine as assessed by the Farnsworth-Munsell 100 hue test.
    Racheva K; Totev T; Natchev E; Bocheva N; Beirne R; Zlatkova M
    J Opt Soc Am A Opt Image Sci Vis; 2023 Mar; 40(3):A26-A32. PubMed ID: 37132999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of color discrimination changes in diabetic patients without diabetic retinopathy].
    Sun TS; Zhang MN
    Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):41-6. PubMed ID: 23601465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New iPAD-based test for the detection of color vision deficiencies.
    de Fez D; Luque MJ; Matea L; Piñero DP; Camps VJ
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2349-2360. PubMed ID: 30291435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a New Digital and Automated Color Perception Test.
    Fanlo-Zarazaga A; Echevarría JI; Pinilla J; Alejandre A; Pérez-Roche T; Gutiérrez D; Ortín M; Pueyo V
    Diagnostics (Basel); 2024 Feb; 14(4):. PubMed ID: 38396435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.